Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07148232 · ClinicalTrials.gov registry record · Phase 4

Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness

A Phase 4 study of Tobacco Use and Tobacco Use Cessation, sponsored by University of California, San Francisco.

Recruiting
Registry status
Phase 4
Development phase
150
Enrollment target
1
Study location

NCT07148232 is a Phase 4 study of Tobacco Use and Tobacco Use Cessation that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 150 participants, below the 377-participant average among 76 other Tobacco Use trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07148232, a Phase 4 study of Tobacco Use and Tobacco Use Cessation, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
Phase 4
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

This study is investigating tobacco use and providing tobacco treatment among people experiencing homelessness in California, in San Francisco and Los Angeles.

Interventions

  • DRUG Nicotine Replacement Therapy (NRT)
  • BEHAVIORAL Wellness Coaching

Study Locations (1)

California

  • University of California, San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2025-11-14
Est. Completion 2027-06-30
Phase Phase 4

What the Registry Record Tells You About NCT07148232

The ClinicalTrials.gov registry entry for NCT07148232 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 377-participant average among 76 other Tobacco Use trials with a reported enrollment target (60% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Tobacco Use appearing as the primary indexed condition, and to 2 interventions - of which Nicotine Replacement Therapy (NRT) is the first listed.

NCT07148232 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT07148232 about?

NCT07148232 is a clinical study titled "Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness". This study is investigating tobacco use and providing tobacco treatment among people experiencing homelessness in California, in San Francisco and Los Angeles.

What is the current status of trial NCT07148232?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2025-11-14. Estimated completion is 2027-06-30.

What conditions does trial NCT07148232 study?

This clinical trial studies the following conditions: Tobacco Use, Tobacco Use Cessation, Tobacco Dependence, Tobacco Cessation, Tobacco Abstinence.

What interventions are being tested in trial NCT07148232?

The interventions under investigation include: Nicotine Replacement Therapy (NRT) (DRUG), Wellness Coaching (BEHAVIORAL).

Who is sponsoring clinical trial NCT07148232?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07148232 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.